Advertisement
Advertisement
U.S. markets open in 2 hours 11 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Alpine Immune Sciences, Inc. (ALPN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
7.11-0.10 (-1.39%)
At close: 04:00PM EDT
6.73 -0.38 (-5.34%)
Pre-Market: 06:52AM EDT
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors

    FLORHAM PARK, N.J., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases and disorders, today announced the appointment of James “Jamie” Topper, M.D., Ph.D., to its Board of Directors. Dr. Topper currently serves as a Managing Partner at Frazier Life Sciences, which invests globally in private and publicly traded companies that discover, develop, and co

  • Business Wire

    Alpine Immune Sciences Announces Pricing of $100 Million Public Offering

    SEATTLE, September 21, 2022--Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced the pricing of its underwritten public offering of 13,606,000 shares of its common stock pursuant to its existing shelf registration statement. The shares of common stock are being offered at a public offering price of $7.35 per share. The gross proceeds to Alpine from the

  • Business Wire

    Alpine Immune Sciences Announces Proposed Public Offering

    SEATTLE, September 20, 2022--Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced that it has commenced an underwritten public offering of $100.0 million of shares of its common stock and, in lieu of shares of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, pursuant to its existing shelf regis

Advertisement
Advertisement